Rankings
▼
Calendar
IRD Q1 2024 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena
IRD
Opus Genetics, Inc.
$349M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-2.2% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$8M
-450.5% margin
Net Income
-$7M
-415.3% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
+1.2%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$985,000
Balance Sheet
Total Assets
$52M
Total Liabilities
$6M
Stockholders' Equity
$46M
Cash & Equivalents
$47M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
-2.2%
Gross Profit
$2M
-$4M
+144.5%
Operating Income
-$8M
-$6M
-25.7%
Net Income
-$7M
-$6M
-22.7%
← FY 2024
All Quarters
Q2 2024 →